4
Changes in Ownership
Starling Oncology, Inc. Filed Acc 0001628280-23-039815
Director sold 25,000 shares at $2.24 ($56,000)
- Director acquired 25,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hively Brad Director | 2023-11-17 | Option exercise | +25,000 | $0.85 | $21,250 | 722,065 | D |
| Hively Brad Director | 2023-11-17 | Sale | −25,000 | $2.24 | $56,000 | 697,065 | D |
| Derivatives | |||||||
| Hively Brad Director | 2023-11-17 | Option exercise · Non-Qualified Stock Option (right to buy) | −25,000 | 1,745,431 | D | ||
| Open-market sales · 25,000 sh · avg $2.24 · $56,000 | |||||||
Loading xslF345X05/wk-form4_1700612843.xml…